Levee Medical

Levee Medical is a clinical-stage medical device innovator targeting a major unmet need in urologic oncology: post-prostatectomy stress urinary incontinence (SUI). The company's lead product, the Voro Urologic Scaffold, is an absorbable device implanted during surgery to support the urinary sphincter and enhance recovery. With its ARID II IDE pivotal trial underway and recent oversubscribed financing, Levee is advancing toward a potential FDA submission, aiming to establish the first device specifically engineered to address this debilitating surgical complication.

Absorbable urologic scaffold designed to provide temporary structural support to the urinary sphincter complex after radical prostatectomy.

Current standard of care is limited to pelvic floor therapy and, for severe cases, secondary implant surgeries (artificial urinary sphincters, slings). The Voro Scaffold is a first-in-class prophylactic intervention with no direct competitors, though other companies may be exploring biomaterial or device-based solutions for post-prostatectomy recovery.